Inhibitory effects and mechanisms of the anti-covid-19 traditional Chinese prescription, Keguan-1, on acute lung injury
급성 폐 손상에 대한 항 코비드 -19 전통 중국 처방, Keguan-1의 억제 효과 및 메커니즘
Article
[키워드] acute lung injury
Adhesion Molecule
Administered
administration
ALI
Alpha
ameliorated
analysed
Ang II
Angiotensin II
ARDS
BALF
breath
cadherin
chemokine
Chinese
claudin
Clinical treatment
clinical trial
collected
coronavirus
coronavirus disease
COVID-19
demonstrated
Diseases
Effect
ELISA
Emerging infectious diseases
Endothelial cell
endothelial injury
expression
Factor
High dose
ICAM-1
IL-1β
IL-6
IMPROVE
incidence
Infectious diseases
Inflammation
Inflammatory
Inflammatory factor
inflammatory factors
inflammatory protein
inhibited
Injury
interleukin
intratracheal instillation
Keguan-1
keratinocyte
lipopolysaccharide
low dose
LPS
lung
Lung injury
lung tissue
lung tissues
Macrophage
material
mechanism
medium dose
mice
Necrosis
neutrophil
Neutrophils
patients with COVID-19
progression
proinflammatory
protective mechanism
Protein
provide
pulmonary
Pulmonary vascular endothelial injury.
randomised
reduced
reducing
Registered
Seven
significantly
Support
survival rate
TCM
therapy
tight junction
TNF-α
Traditional Chinese medicine
treat
Tumour necrosis factor alpha
Vascular
VE-cadherin
was used
western blotting
[DOI] 10.1016/j.jep.2021.114838 PMC 바로가기 [Article Type] Article
[DOI] 10.1016/j.jep.2021.114838 PMC 바로가기 [Article Type] Article